Gastrointestinal Health

Understanding gastrointestinal health

The gastrointestinal (GI) system is certainly no simple structure, operating far beyond its primary role in digestion.

At its core is the gut microbiome – a diverse ecosystem of trillions of microorganisms that profoundly influence both digestive and overall health. For formulators developing gut health products, understanding this complexity is vital. The gut microbiome’s influence on gastrointestinal health operates through multiple pathways, including barrier function maintenance, nutrient absorption, metabolite production, and immune system modulation.

The gut microbiome GI health connection

The relationship between the gut microbes and gastrointestinal health is remarkably complex and bidirectional.

Research demonstrates that the composition of bacteria in the gut microbiome can significantly influence digestive function, nutrient absorption, and overall gastrointestinal wellbeing.

As our understanding of the gut microbiome advances, it’s becoming increasingly clear that disruptions to the bacterial balance present can contribute to various gastrointestinal challenges.

This evolving scientific understanding creates new opportunities for formulators to approach gastrointestinal health through targeted microbiome modulation, including through prebiotics.

This intricate ecosystem helps maintain the integrity of the intestinal barrier, produces essential metabolites, and supports regular digestive processes.

When the proportion of beneficial bacteria decreases relative to less advantageous types, it can lead to commonly reported digestive symptoms such as bloating, irregular bowel movements, and general gastrointestinal discomfort.

Common gastrointestinal challenges

Gastrointestinal disorders affect millions globally, with Irritable Bowel Syndrome (IBS), widely estimated to impact 10-15% of the global population. IBS is typically characterised through gastrointestinal symptoms, such as trapped wind and bloating, digestive discomfort and diarrhoea, which represents significant opportunities for targeted product development.

Prebiotic supplementation offers a scientifically validated approach to supporting gastrointestinal health through selective microbiome modulation, which is ideal for both IBS-specific products, as well as those aimed at supporting digestive health in more general ways. Clinical studies demonstrate that targeted prebiotic intervention can help:

Scientific innovation in prebiotic technology

Galactooligosaccharides (GOS) are proving particularly effective prebiotics for gastrointestinal health support. Their structural similarity to human milk oligosaccharides (HMOs) makes them highly selective for beneficial bacteria, particularly bifidobacteria and lactobacilli.

 

Bimuno® GOS exemplifies this scientific innovation, with over 120 publications and more than 20 clinical studies supporting its efficacy, including in matters of gastrointestinal health. Clinical studies demonstrate improvements in both healthy individuals and those with reported symptoms of IBS, making it an excellent choice for targeted formulations.

Key research highlights

A number of landmark studies are widely referenced across the prebiotics category, that were specifically conducted using Bimuno GOS. Through this targeted clinical research, our prebiotic functional ingredient is shown to:

Your partner in innovation

Our team of experts can help you navigate the complexities of gastrointestinal health product development, through the lens of prebiotics. With access to market leading prebiotic fibre technology and comprehensive scientific support, we can help you create effective, evidence-based solutions that meet real-world consumer needs.

Explore further:

Ready to explore how our scientific expertise can support your product development?

Contact our team to learn more about the research behind Bimuno GOS and its applications in your formulations.